Ftse Mib
33.541,98
-0,49%
DAX
18.155,24
-0,04%
S&P 500
5.477,90
0,16%
NASDAQ
17.805,16
0,49%
Bitcoin
60.829,20
-1,59%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intelligent Bio Solutions Inc (INBS) Intelligent Bio Solutions Inc (INBS) Notizie

INBS

Intelligent Bio Solutions (INBS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INBS
DataOraFonteTitoloSimboloCompagnia
20/06/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics SectorNASDAQ:INBSIntelligent Bio Solutions Inc
18/06/202423:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INBSIntelligent Bio Solutions Inc
18/06/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
18/06/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening TechnologyNASDAQ:INBSIntelligent Bio Solutions Inc
13/06/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth InitiativesNASDAQ:INBSIntelligent Bio Solutions Inc
12/06/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening TechnologyNASDAQ:INBSIntelligent Bio Solutions Inc
06/06/202414:30GlobeNewswire Inc.Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024NASDAQ:INBSIntelligent Bio Solutions Inc
29/05/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) StudyNASDAQ:INBSIntelligent Bio Solutions Inc
23/05/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective SolutionsNASDAQ:INBSIntelligent Bio Solutions Inc
17/05/202414:30GlobeNewswire Inc.Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety EventNASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202414:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
18/04/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
11/04/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderNASDAQ:INBSIntelligent Bio Solutions Inc
26/03/202413:30GlobeNewswire Inc.Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCNASDAQ:INBSIntelligent Bio Solutions Inc
13/03/202400:30GlobeNewswire Inc.Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
11/03/202413:30GlobeNewswire Inc.Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
04/03/202423:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INBSIntelligent Bio Solutions Inc
28/02/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayNASDAQ:INBSIntelligent Bio Solutions Inc
16/02/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity RequirementNASDAQ:INBSIntelligent Bio Solutions Inc
15/02/202400:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
09/02/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
05/02/202415:00GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross ProceedsNASDAQ:INBSIntelligent Bio Solutions Inc
02/02/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
30/01/202414:30GlobeNewswire Inc.Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces AcceleratesNASDAQ:INBSIntelligent Bio Solutions Inc
29/01/202414:30GlobeNewswire Inc.Leading UK Timber Processor and Packaging Manufacturer, James Jones & Sons Ltd., Adopts Intelligent Bio Solutions’ Fingerprint Drug Screening System Across its 25 Sites and 1,300 EmployeesNASDAQ:INBSIntelligent Bio Solutions Inc
25/01/202414:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Reverse Stock SplitNASDAQ:INBSIntelligent Bio Solutions Inc
22/01/202414:30GlobeNewswire Inc.DGP Plc Takes Drug Testing In-house with Fingerprint Sweat-based TestingNASDAQ:INBSIntelligent Bio Solutions Inc
18/01/202414:30GlobeNewswire Inc.UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening SystemNASDAQ:INBSIntelligent Bio Solutions Inc
12/01/202423:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INBSIntelligent Bio Solutions Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INBS

La tua Cronologia

LSE
PDD1
1x Pdd
ASX
SPA
Spacetalk
NASDAQ
AGAM
BIT
F34041
Vontobel Financial Produ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network